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:~ NB, Newborn. § The negative sign indicates no seroconversion or recovery of HIV from the animals.
The presence of HIV in the spleen, PMC, blood and serum of animals was measured in a standard cell culture system (Levy et al., 1984 (Levy et al., , 1985a . Spleens from mice, rats, guinea-pigs and shrews were placed directly into culture in the presence of 10~ human interleukin-2 (IL-2) (T cell growth supplement, Meloy Laboratories, Springfield, Va., U.S.A.). Blood samples (approximately 0-5 ml) from these animals were cultured directly in medium containing IL-2. Spleen cells from rabbits were separated on Ficoll-Hypaque gradients before being cultured.
The spleen cells were stimulated for 3 days with phytohaemagglutinin (PHA) (Levy et al., 1984) and then replated in the growth medium. Moreover, some cells were mixed with PHAstimulated PMC from seronegative human donors. Serum (0-1 to 0.5 ml) from the animals was inoculated directly onto mitogen-stimulated human PMC obtained from normal HIV-negative volunteers (Levy et al., 1985 b) . The supernatant fluid from aU cultures was assayed for particleassociated RT activity (Hoffman et al., 1985) every 3 days for up to 2 months. Antibodies to HIV in the animals were measured by an indirect immunofluorescence assay or an immunoblot procedure using HUT-78 cells chronically infected with HIVsF 2 (Kaminsky et al., 1985; Pan et al., 1987) . At approximately 3 to 6 month intervals, blood smears were made from the inoculated mice and stained with 'Stat' stain (VWR, Brisbane, Ca., U.S.A.). Tissues from sacrificed or dead animals were fixed in formalin, and examined by standard procedures. No unexplained mortalities or pathologies were observed in any of the 30 rats, 16 hamsters or 14 guinea-pigs inoculated with the clinical specimens. Moreover, none of the hamsters and guinea-pigs seroconverted. Sera from the rats were not available for testing. Twelve newborn and six juvenile rabbits inoculated with HIV showed neither seroconversion nor virus in their spleen cells or PMC. Similar results were obtained with shrews injected with HIV (six with HIVsF 2 and three with HIVSF33 ) (Table 1) .
In experiments with 300 mice (from approximately 50 litters of different strains), a significantly higher mortality was noted in the experimental animals receiving specimens from AIDS or ARC patients (18.7~), than in those receiving material from healthy controls (5.3 ~) (P<0-025 > 0-01 chi-square test) ( Table 2) . Death appeared to be due to a variety of pathologies, including runting, tumours and opportunistic infections. The latter were indicated by chronic diarrhoea, pneumonitis and dermatological disorders. In some mice, fibrotic spleens were noted, but extracts of these tissues or fluids from the cultured splenic cells did not induce disease in recipient mice. Blood smears revealed numerous abnormalities in the test animals (Table 3) , but the direct cause of these pathologies could not be determined. Neither infectious HIV nor antibodies to the virus could be detected in blood cultures or sera from any of the mice.
When HIVsv2 was inoculated into six litters of newborn BALB/c and two litters of MRL/lpr
mice, a higher mortality was noted in the experimental animals than in the control group (Table  2) , but it was not statistically significant (0-3 < P ~> 0-5, chi-square test). Moreover, infectious * The figures indicate the numbers of deaths that occurred in the total number of inoculated animals during the first 12 months of life. Losses due to attrition in the infancy period (4 weeks post-injection) are not included.
l" Statistically significant (P < 0.025 > 0.01, chi-square test). :~ Although the experimental group of animals had a higher incidence of mortality than the controls, this result was not statistically significant. § ND, Not done. * In 6-month-old mice, the normal ranges are approximately neutrophils, 10 to 25 ~; lymphocytes, 65 to 90 ~; eosinophils, 0.5 to 5~; monocytes, 0-5 to 5~.
HIV and seroconversion were not observed in these inoculated mice. Finally, in an attempt to adapt a variant of HIV to mice, HIVsFz was passaged at 2-week intervals, using two litters of animals (BALB/c) per passage. At each of seven passages, the animals were sacrificed, their spleens were removed and cultured for virus. One portion of cells was inoculated into a new group of newborn animals. Neither replicating HIV nor seroconversion was detected in any animals. 
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